Hélène Lasolle

1.5k total citations
38 papers, 523 citations indexed

About

Hélène Lasolle is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Hélène Lasolle has authored 38 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Endocrinology, Diabetes and Metabolism, 16 papers in Surgery and 9 papers in Genetics. Recurrent topics in Hélène Lasolle's work include Pituitary Gland Disorders and Treatments (25 papers), Adrenal and Paraganglionic Tumors (12 papers) and Glioma Diagnosis and Treatment (9 papers). Hélène Lasolle is often cited by papers focused on Pituitary Gland Disorders and Treatments (25 papers), Adrenal and Paraganglionic Tumors (12 papers) and Glioma Diagnosis and Treatment (9 papers). Hélène Lasolle collaborates with scholars based in France, Romania and Italy. Hélène Lasolle's co-authors include Gérald Raverot, Mirela Diana Ilie, Alexandre Vasiljevic, Françoise Borson‐Chazot, Emmanuel Jouanneau, Jacqueline Trouillas, Vincent Amodru, Frédéric Castinetti, Thierry Brue and Véronique Raverot and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Hélène Lasolle

36 papers receiving 513 citations

Peers

Hélène Lasolle

EDM

SURGE

GENET

EPIDE

Mirela Diana Ilie France

Maria Maksymowicz Poland

Humberto Uribe Canada

Elena V Varlamov United States

Christine Cortet France

Tomás Lúcas Spain

Donato Iacovazzo United Kingdom

Luiz Roberto Salgado Brazil

Diana Sprij-Mooij Netherlands

I Morange-Ramos France

Mirela Diana Ilie France

Hélène Lasolle

441 ×1.0

EDM

134 ×0.7

SURGE

262 ×1.4

GENET

180 ×1.3

EPIDE

88 ×1.4

Citations per year, relative to Hélène Lasolle Hélène Lasolle (= 1×) peers Mirela Diana Ilie

Countries citing papers authored by Hélène Lasolle

Since Specialization

Citations

This map shows the geographic impact of Hélène Lasolle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hélène Lasolle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hélène Lasolle more than expected).

Fields of papers citing papers by Hélène Lasolle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hélène Lasolle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hélène Lasolle. The network helps show where Hélène Lasolle may publish in the future.

Co-authorship network of co-authors of Hélène Lasolle

This figure shows the co-authorship network connecting the top 25 collaborators of Hélène Lasolle. A scholar is included among the top collaborators of Hélène Lasolle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hélène Lasolle. Hélène Lasolle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lasolle, Hélène, Charles Dupin, J. Abeillon, et al.. (2025). Outcomes and Therapeutic Strategies for Head-and-neck Paragangliomas Associated With Succinate Dehydrogenase Mutations. The Journal of Clinical Endocrinology & Metabolism. 110(12). e4030–e4037. 1 indexed citations

Decaussin‐Petrucci, Myriam, Françoise Descôtes, Gérald Raverot, et al.. (2025). From hyperplasia to carcinoma: a molecular driven adrenal disease. European Journal of Endocrinology. 192(6). K55–K59.

Lasolle, Hélène, Christine Do Cao, Livia Lamartina, et al.. (2025). ENDOCAN-TUTHYREF network consensus recommendations. Refractory medullary thyroid cancer. Annales d Endocrinologie. 86(4). 101733–101733.

Tabarin, Antoine, Jérôme Bertherat, Bénédicte Decoudier, et al.. (2025). Real-World Osilodrostat Effectiveness and Safety in Nonpituitary Cushing Syndrome. The Journal of Clinical Endocrinology & Metabolism. 2 indexed citations

Lasolle, Hélène, Livia Lamartina, Camille Buffet, et al.. (2024). Patients with medullary thyroid carcinoma and long term treatment with vandetanib: a study from the endocan -tuthyref network. Endocrine Abstracts. 1 indexed citations

Lasolle, Hélène, et al.. (2024). Pronosthyc: Prognostic factors in radioiodine refractory differentiated thyroid cancer with distant metastases, a multicentric study from the French ENDOCAN-TUTHYREF Network. Annales d Endocrinologie. 85(5). 387–388. 1 indexed citations

Perez‐Rivas, Luis Gustavo, Yining Zhao, Hélène Lasolle, et al.. (2023). Prevalence and clinical correlations of SF3B1 variants in lactotroph tumours. European Journal of Endocrinology. 189(3). 372–378. 17 indexed citations

Romitti, Mírian, Gilles Doumont, Hélène Lasolle, et al.. (2023). Transplantable human thyroid organoids generated from embryonic stem cells to rescue hypothyroidism. Yearbook of pediatric endocrinology. 1 indexed citations

Lasolle, Hélène, Alexandre Vasiljevic, Emmanuel Jouanneau, Mirela Diana Ilie, & Gérald Raverot. (2022). Aggressive corticotroph tumors and carcinomas. Journal of Neuroendocrinology. 34(8). e13169–e13169. 23 indexed citations

10.

Lasolle, Hélène, Jonathan Lopez, François Pattou, et al.. (2022). SFE-AFCE-SFMN 2022 Consensus on the management of thyroid nodules : Role of molecular tests for cytologically indeterminate thyroid nodules. Annales d Endocrinologie. 83(6). 395–400. 7 indexed citations

11.

Jacquesson, Timothée, Romain Manet, Alexandre Vasiljevic, et al.. (2022). Neoadjuvant B-RAF and MEK Inhibitor Targeted Therapy for Adult Papillary Craniopharyngiomas: A New Treatment Paradigm. Frontiers in Endocrinology. 13. 882381–882381. 32 indexed citations

12.

Lasolle, Hélène, Léopoldine Bricaire, Erika Cornu, et al.. (2022). Pneumocystis pneumonia in patients with Cushing's syndrome: A French multicenter retrospective study. Annales d Endocrinologie. 84(1). 37–44. 11 indexed citations

13.

Acheampong, Angela, Hélène Lasolle, Caroline Verhoeven, et al.. (2022). A Preclinical Rat Model of Heart Failure With Preserved Ejection Fraction With Multiple Comorbidities. Frontiers in Cardiovascular Medicine. 8. 809885–809885. 9 indexed citations

14.

Raverot, Gérald, Mirela Diana Ilie, Hélène Lasolle, et al.. (2021). Aggressive pituitary tumours and pituitary carcinomas. Nature Reviews Endocrinology. 17(11). 671–684. 92 indexed citations

15.

Lasolle, Hélène, Mad‐Hélénie Elsensohn, Anne Wierinckx, et al.. (2020). Chromosomal instability in the prediction of pituitary neuroendocrine tumors prognosis. Acta Neuropathologica Communications. 8(1). 190–190. 27 indexed citations

16.

Lasolle, Hélène, Mirela Diana Ilie, & Gérald Raverot. (2019). Aggressive prolactinomas: how to manage?. Pituitary. 23(1). 70–77. 28 indexed citations

17.

Ilie, Mirela Diana, Hélène Lasolle, & Gérald Raverot. (2019). Emerging and Novel Treatments for Pituitary Tumors. Journal of Clinical Medicine. 8(8). 1107–1107. 43 indexed citations

18.

Lasolle, Hélène, Alexandre Vasiljevic, Françoise Borson‐Chazot, & Gérald Raverot. (2018). Pasireotide: A potential therapeutic alternative for resistant prolactinoma. Annales d Endocrinologie. 80(2). 84–88. 41 indexed citations

19.

Lasolle, Hélène & Gérald Raverot. (2016). Therapeutic innovations in endocrine diseases – part 3 : temozolomide and future therapeutics for aggressive pituitary tumors and carcinomas. La Presse Médicale. 45(6). e211–e216. 5 indexed citations

20.

Lasolle, Hélène & Gérald Raverot. (2015). Pituitary siderosis: the dark side of the pituitary. The Lancet Diabetes & Endocrinology. 4(4). 374–374. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact